Geode Capital Management LLC Boosts Holdings in Pulmatrix, Inc. (NASDAQ:PULM)

Geode Capital Management LLC raised its holdings in shares of Pulmatrix, Inc. (NASDAQ:PULM) by 24.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 36,871 shares of the biotechnology company’s stock after buying an additional 7,290 shares during the period. Geode Capital Management LLC owned about 1.01% of Pulmatrix worth $257,000 at the end of the most recent quarter.

Separately, SBI Securities Co. Ltd. purchased a new stake in shares of Pulmatrix in the 4th quarter worth $462,000. Hedge funds and other institutional investors own 11.84% of the company’s stock.

Pulmatrix Trading Down 2.1 %

Shares of NASDAQ:PULM opened at $6.38 on Friday. The stock has a 50 day moving average of $6.72 and a 200 day moving average of $6.08. The company has a market cap of $23.29 million, a PE ratio of -2.42 and a beta of 1.38. Pulmatrix, Inc. has a 12-month low of $1.72 and a 12-month high of $10.40.

Pulmatrix (NASDAQ:PULM) last announced its quarterly earnings data on Friday, March 21st. The biotechnology company reported ($0.54) EPS for the quarter. Pulmatrix had a negative net margin of 96.51% and a negative return on equity of 45.97%.

Analyst Ratings Changes

Separately, StockNews.com started coverage on Pulmatrix in a research report on Sunday, January 5th. They set a “hold” rating on the stock.

About Pulmatrix

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.